|
1
|
Kapałczyńska M, Kolenda T, Przybyła W,
Zajączkowska M, Teresiak A, Filas V, Ibbs M, Bliźniak R, Łuczewski
Ł and Lamperska K: 2D and 3D cell cultures-a comparison of
different types of cancer cell cultures. Arch Med Sci. 14:910–919.
2018.PubMed/NCBI
|
|
2
|
Boghaert ER, Lu X, Hessler PE, McGonigal
TP, Oleksijew A, Mitten MJ, Foster-Duke K, Hickson JA, Santo VE,
Brito C, et al: The volume of three-dimensional cultures of cancer
cells in vitro influences transcriptional profile differences and
similarities with monolayer cultures and xenografted tumors.
Neoplasia. 19:695–706. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hirschhaeuser F, Menne H, Dittfeld C, West
J, Mueller-Klieser W and Kunz-Schughart LA: Multicellular tumor
spheroids: An underestimated tool is catching up again. J
Biotechnol. 148:3–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Valkenburg KC, de Groot AE and Pienta KJ:
Targeting the tumour stroma to improve cancer therapy. Nat Rev Clin
Oncol. 15:366–381. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hay M, Thomas DW, Craighead JL, Economides
C and Rosenthal J: Clinical development success rates for
investigational drugs. Nat Biotechnol. 32:40–51. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Martin L, Hutchens M, Hawkins C and Radnov
A: How much do clinical trials cost? Nat Rev Drug Discov.
16:381–382. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Baru A, Mazumder S, Kundu PK, Sharma S,
Das Purkayastha BP, Khan S, Gupta R and Mehrotra Arora N:
Recapitulating tumor microenvironment using AXTEX-4DTM for
accelerating cancer research and drug screening. Asian Pac J Cancer
Prev. 23:561–571. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Haisler WL, Timm DM, Gage JA, Tseng H,
Killian TC and Souza GR: Three-dimensional cell culturing by
magnetic levitation. Nat Protoc. 8:1940–1949. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lv D, Hu Z, Lu L, Lu H and Xu X:
Three-dimensional cell culture: A powerful tool in tumor research
and drug discovery. Oncol Lett. 14:6999–7010. 2017.PubMed/NCBI
|
|
10
|
Imamura Y, Mukohara T, Shimono Y,
Funakoshi Y, Chayahara N, Toyoda M, Kiyota N, Takao S, Kono S,
Nakatsura T and Minami H: Comparison of 2D- and 3D-culture models
as drug-testing platforms in breast cancer. Oncol Rep.
33:1837–1843. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baru A, Sharma S, Purakayastha BP, Khan S,
Mazumdar S, Gupta R, Kundu PK and Arora NM: AXTEX-4D: A
three-dimensional ex vivo platform for preclinical investigations
of immunotherapy agents. Assay Drug Dev Technol. 19:361–372. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Baru A, Mazumdar S, Kundu P, Sharma S,
Purakayastha BP, Khan S, Gupta R and Arora NM: Recapitulating tumor
microenvironment using preclinical 3D tissueoids model for
accelerating cancer research and drug screening. bioRxiv. Dec
22–2020.(Epub ahead of print).
|
|
13
|
Bray LJ, Secker C, Murekatete B, Sievers
J, Binner M, Welzel PB and Werner C: Three-dimensional in vitro
hydro- and cryogel-based cell-culture models for the study of
breast-cancer metastasis to bone. Cancers (Basel). 10:2922018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wu Y, Wu H, Zeng J, Pluimer B, Dong S, Xie
X, Guo X, Ge T, Liang X, Feng S, et al: Mild traumatic brain injury
induces microvascular injury and accelerates Alzheimer-like
pathogenesis in mice. Acta Neuropathol Commun. 9:742021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Eilenberger C, Kratz SRA, Rothbauer M,
Ehmoser EK, Ertl P and Küpcü S: Optimized alamarBlue assay protocol
for drug dose-response determination of 3D tumor spheroids.
MethodsX. 5:781–787. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lazzari G, Nicolas V, Matsusaki M, Akashi
M, Couvreur P and Mura S: Multicellular spheroid based on a triple
co-culture: A novel 3D model to mimic pancreatic tumor complexity.
Acta Biomater. 78:296–307. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lamichhane SP, Arya N, Kohler E, Xiang S,
Christensen J and Shastri VP: Recapitulating epithelial tumor
microenvironment in vitro using three dimensional tri-culture of
human epithelial, endothelial, and mesenchymal cells. BMC Cancer.
16:5812016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shah PP, Dupre TV, Siskind LJ and Beverly
LJ: Common cytotoxic chemotherapeutics induce
epithelial-mesenchymal transition (EMT) downstream of ER stress.
Oncotarget. 8:22625–22639. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bai C, Yang M, Fan Z, Li S, Gao T and Fang
Z: Associations of chemo- and radio-resistant phenotypes with the
gap junction, adhesion and extracellular matrix in a
three-dimensional culture model of soft sarcoma. J Exp Clin Cancer
Res. 34:582015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Senthebane DA, Jonker T, Rowe A, Thomford
NE, Munro D, Dandara C, Wonkam A, Govender D, Calder B, Soares NC,
et al: The role of tumor microenvironment in chemoresistance: 3D
extracellular matrices as accomplices. Int J Mol Sci. 19:28612018.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ellis MJ, Suman VJ, Hoog J, Goncalves R,
Sanati S, Creighton CJ, DeSchryver K, Crouch E, Brink A, Watson M,
et al: Ki67 proliferation index as a tool for chemotherapy
decisions during and after neoadjuvant aromatase inhibitor
treatment of breast cancer: Results from the American college of
surgeons oncology group Z1031 trial (alliance). J Clin Oncol.
35:1061–1069. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Plant AL, Bhadriraju K, Spurlin TA and
Elliott JT: Cell response to matrix mechanics: Focus on collagen.
Biochim Biophys Acta. 1793:893–902. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mak KM and Mei R: Basement membrane type
IV collagen and laminin: An overview of their biology and value as
fibrosis biomarkers of liver disease. Anat Rec (Hoboken).
300:1371–1390. 2017. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nugroho RWN, Harjumäki R, Zhang X, Lou YR,
Yliperttula M, Valle-Delgado JJ and Österberg M: Quantifying the
interactions between biomimetic biomaterials-collagen I, collagen
IV, laminin 521 and cellulose nanofibrils-by colloidal probe
microscopy. Colloids Surf B Biointerfaces. 173:571–580. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Koeck S, Zwierzina M, Lorenz E, Gamerith
G, Zwierzina H and Amann A: Infiltration of immune cells into
cancer cell/stroma cell 3D microtissues. J Immunother Cancer. 3
(Suppl 2):P752015. View Article : Google Scholar
|
|
26
|
Bray LJ, Binner M, Körner Y, von Bonin M,
Bornhäuser M and Werner C: A three-dimensional ex vivo tri-culture
model mimics cell-cell interactions between acute myeloid leukemia
and the vascular niche. Haematologica. 102:1215–1226. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bruce A, Evans R, Mezan R, Shi L, Moses
BS, Martin KH, Gibson LF and Yang Y: Three-dimensional microfluidic
tri-culture model of the bone marrow microenvironment for study of
acute lymphoblastic leukemia. PLoS One. 10:e01405062015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liston DR and Davis M: Clinically relevant
concentrations of anticancer drugs: A guide for nonclinical
studies. Clin Cancer Res. 23:3489–3498. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Balaburski GM, Dardes RC, Johnson M,
Haddad B, Zhu F, Ross EA, Sengupta S, Klein-Szanto A, Liu H, Lee
ES, et al: Raloxifene-stimulated experimental breast cancer with
the paradoxical actions of estrogen to promote or prevent tumor
growth: A unifying concept in anti-hormone resistance. Int J Oncol.
37:387–398. 2010.PubMed/NCBI
|
|
30
|
Brady H, Desai S, Gayo-Fung LM,
Khammungkhune S, McKie JA, O'Leary E, Pascasio L, Sutherland MK,
Anderson DW, Bhagwat SS and Stein B: Effects of SP500263, a novel,
potent antiestrogen, on breast cancer cells and in xenograft
models. Cancer Res. 62:1439–1442. 2002.PubMed/NCBI
|
|
31
|
Schafer JM and Jordan VC: Models of
hormone resistance in vitro and in vivo. Methods Mol Med.
120:453–464. 2006.PubMed/NCBI
|
|
32
|
Azab SS, Salama SA, Hassan MH, Khalifa AE,
El-Demerdash E, Fouad H, Al-Hendy A and Abdel-Naim AB:
2-Methoxyestradiol reverses doxorubicin resistance in human breast
tumor xenograft. Cancer Chemother Pharmacol. 62:893–902. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mansoori B, Mohammadi A, Davudian S,
Shirjang S and Baradaran B: The different mechanisms of cancer drug
resistance: A brief review. Adv Pharm Bull. 7:339–348. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Walter M, Liang S, Ghosh S, Hornsby PJ and
Li R: Interleukin 6 secreted from adipose stromal cells promotes
migration and invasion of breast cancer cells. Oncogene.
28:2745–2755. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Neiva KG, Warner KA, Campos MS, Zhang Z,
Moren J, Danciu TE and Nör JE: Endothelial cell-derived
interleukin-6 regulates tumor growth. BMC Cancer. 14:992014.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Baghban R, Roshangar L, Jahanban-Esfahlan
R, Seidi K, Ebrahimi-Kalan A, Jaymand M, Kolahian S, Javaheri T and
Zare P: Tumor microenvironment complexity and therapeutic
implications at a glance. Cell Commun Signal. 18:592020. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yamaguchi H and Sakai R: Direct
interaction between carcinoma cells and cancer associated
fibroblasts for the regulation of cancer invasion. Cancers (Basel).
7:2054–2062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Akino T, Hida K, Hida Y, Tsuchiya K,
Freedman D, Muraki C, Ohga N, Matsuda K, Akiyama K, Harabayashi T,
et al: Cytogenetic abnormalities of tumor-associated endothelial
cells in human malignant tumors. Am J Pathol. 175:2657–2667. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Winkler J, Abisoye-Ogunniyan A, Metcalf KJ
and Werb Z: Concepts of extracellular matrix remodelling in tumour
progression and metastasis. Nat Commun. 11:51202020. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Grigioni WF, Garbisa S, D'Errico A,
Baccarini P, Stetler-Stevenson WG, Liotta LA and Mancini AM:
Evaluation of hepatocellular carcinoma aggressiveness by a panel of
extracellular matrix antigens. Am J Pathol. 138:647–654.
1991.PubMed/NCBI
|
|
41
|
Nürnberg E, Vitacolonna M, Klicks J, von
Molitor E, Cesetti T, Keller F, Bruch R, Ertongur-Fauth T, Riedel
K, Scholz P, et al: Routine optical clearing of 3D-cell cultures:
Simplicity forward. Front Mol Biosci. 7:202020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Imbalzano KM, Tatarkova I, Imbalzano AN
and Nickerson JA: Increasingly transformed MCF-10A cells have a
progressively tumor-like phenotype in three-dimensional basement
membrane culture. Cancer Cell Int. 9:72009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Alessandri K, Sarangi BR, Gurchenkov VV,
Sinha B, Kießling TR, Fetler L, Rico F, Scheuring S, Lamaze C,
Simon A, et al: Cellular capsules as a tool for multicellular
spheroid production and for investigating the mechanics of tumor
progression in vitro. Proc Natl Acad Sci USA. 110:14843–14848.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Raghavan S, Mehta P, Horst EN, Ward MR,
Rowley KR and Mehta G: Comparative analysis of tumor spheroid
generation techniques for differential in vitro drug toxicity.
Oncotarget. 7:16948–16961. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Loessner D, Stok KS, Lutolf MP, Hutmacher
DW, Clements JA and Rizzi SC: Bioengineered 3D platform to explore
cell-ECM interactions and drug resistance of epithelial ovarian
cancer cells. Biomaterials. 31:8494–8506. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Karlsson H, Fryknäs M, Larsson R and
Nygren P: Loss of cancer drug activity in colon cancer HCT-116
cells during spheroid formation in a new 3-D spheroid cell culture
system. Exp Cell Res. 318:1577–1585. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Trédan O, Galmarini CM, Patel K and
Tannock IF: Drug resistance and the solid tumor microenvironment. J
Natl Cancer Inst. 99:1441–1454. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Barbosa MA, Xavier CP, Pereira RF,
Petrikaite V and Vasconcelos MH: 3D cell culture models as
recapitulators of the tumor microenvironment for the screening of
anti-cancer drugs. Cancers (Basel). 14:1902021. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Edmondson R, Broglie JJ, Adcock AF and
Yang L: Three-dimensional cell culture systems and their
applications in drug discovery and cell-based biosensors. Assay
Drug Dev Technol. 12:207–218. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Yip D and Cho CH: A multicellular 3D
heterospheroid model of liver tumor and stromal cells in collagen
gel for anti-cancer drug testing. Biochem Biophys Res Commun.
433:327–332. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Benton G, DeGray G, Kleinman HK, George J
and Arnaoutova I: In vitro microtumors provide a physiologically
predictive tool for breast cancer therapeutic screening. PLoS One.
10:e01233122015. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Cornelison RC, Yuan JX, Tate KM, Petrosky
A, Beeghly GF, Bloomfield M, Schwager SC, Berr AL, Cimini D,
Bafakih FF, et al: A patient-designed tissue-engineered model of
the infiltrative glioblastoma microenvironment. bioRxiv. Jul
29–2020.(Epub ahead of print).
|
|
53
|
Wan X, Hou J, Liu S, Zhang Y, Li W, Zhang
Y and Ding Y: Estrogen receptor α mediates doxorubicin sensitivity
in breast cancer cells by regulating E-cadherin. Front Cell Dev
Biol. 9:5835722021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Halldorsson S, Lucumi E, Gómez-Sjöberg R
and Fleming RM: Advantages and challenges of microfluidic cell
culture in polydimethylsiloxane devices. Biosens Bioelectron.
63:218–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Ventola CL: Medical applications for 3D
printing: Current and projected uses. P T. 39:704–711.
2014.PubMed/NCBI
|
|
56
|
Marangoni E, Vincent-Salomon A, Auger N,
Degeorges A, Assayag F, de Cremoux P, de Plater L, Guyader C, De
Pinieux G, Judde JG, et al: A new model of patient tumor-derived
breast cancer xenografts for preclinical assays. Clin Cancer Res.
13:3989–3998. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cottu P, Marangoni E, Assayag F, de
Cremoux P, Vincent-Salomon A, Guyader Ch, de Plater L, Elbaz C,
Karboul N, Fontaine JJ, et al: Modeling of response to endocrine
therapy in a panel of human luminal breast cancer xenografts.
Breast Cancer Res Treat. 133:595–606. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhang X, Claerhout S, Prat A, Dobrolecki
LE, Petrovic I, Lai Q, Landis MD, Wiechmann L, Schiff R, Giuliano
M, et al: A renewable tissue resource of phenotypically stable,
biologically and ethnically diverse, patient-derived human breast
cancer xenograft models. Cancer Res. 73:4885–4897. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Fong EL, Martinez M, Yang J, Mikos AG,
Navone NM, Harrington DA and Farach-Carson MC: Hydrogel-based 3D
model of patient-derived prostate xenograft tumors suitable for
drug screening. Mol Pharm. 11:2040–2050. 2014. View Article : Google Scholar : PubMed/NCBI
|
